✦ LIBER ✦

Comparison of survivals in patients with cancer of the lung who are potentially curable using various types of treatment modalities

✍ Scribed by Nejat Akbiyik; Julius Garvey; James Davenport; Enio Solisio; Engracio Cortes; Leslie Alexander

Publisher: Elsevier Science
Year: 1978
Tongue: English
Weight: 162 KB
Volume: 4
Category: Article
ISSN: 0360-3016
DOI: 10.1016/0360-3016(78)90407-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of survivals in patients with

Comparison of survivals in patients with non oat cell carcinoma of the lung using various types of treatment modalities

✍ Nejat Akbiyik; Julius Garvey; Jagmohan Kalra; Leslie L. Alexander 📂 Article 📅 1981 🏛 Elsevier Science 🌐 English ⚖ 211 KB

Comparison of survival in patients with

Comparison of survival in patients with non-oat cell carcinoma of lung using various types of treatment modalities

✍ Nejat Akbiyik; Julius Garvey; Jagmohan Kalra; Leslie Alexander 📂 Article 📅 1982 🏛 Elsevier Science 🌐 English ⚖ 432 KB

Phase 2 trial of docetaxel and gefitinib

Phase 2 trial of docetaxel and gefitinib in the first-line treatment of patients with advanced nonsmall-cell lung cancer (NSCLC) who are 70 years of age or older

✍ George R. Simon; Martine Extermann; Alberto Chiappori; Charles C. Williams; Mube 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 181 KB 👁 2 views

## Abstract ## BACKGROUND This is a phase 2 study of chemotherapy‐naive patients, 70 years of age or older, with nonsmall‐cell lung cancer (NSCLC) who were treated with docetaxel and gefitinib. The primary endpoint was response rate (RR). Secondary endpoints were overall survival (OS) and progress